Subscribe to Search results

Dr Ojala of Cutter sent a memo to Wilhelm Schaeffler to discuss a review of possible courses of action where donors with AIDS were discovered to have donated to plasma pools.

Published on:

At the request of the FDA, representatives of the fractionators met FDA officials to discuss the approach to be taken to future recall of products.

Published on:

Following the first withdrawal of products by Hyland the National Hemophilia Foundation had continued to urge its members to use factor concentrates.

Published on:

The National Hemophilia Foundation restated its original position statement that products should be automatically recalled where a donor was diagnosed with AIDS or characteristics strongly suggestive of AIDS.

Published on:

The minutes of a meeting held at NIBSC highlighted that the issue of withdrawal was not approached purely as a scientific one, but as a question of policy that took into account concerns pertaining to economics and the perceived need to maintain the supply of fractionated blood products.

Published on:

Patient information leaflets became a legal requirement in the UK for all medicines.

Published on:

Cutter confirmed that all plasma was being collected from FDA licensed and inspected centres.

Published on:

William Srigley of Cutter Pharmaceutical gave evidence that he was aware before July 1982 that a homosexual donor who was hepatitis positive risked transmitting AIDS.

Published on:

The evidence is that after February 1983 any remaining stocks of factor concentrates that had been prepared by Cutter using prison plasma were used for research and development purposes only.

Published on:

"The New England Journal of Medicine", published an article by Gottlieb et al titled "Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men".

Published on:

The New England Journal of Medicine published an article by Masur et al titled "An outbreak of community-acquired pneumocystis carinii pneumonia".

Published on:

The New England Journal of Medicine published an article by Durack titled "Opportunistic infections and Kaposi's sarcoma in homosexual men".

Published on:

Strategy caucuses of the plasma collection and manufacturing interests in advance of their meeting regulators, the CDC and others were to become a common occurrence.

Published on:

Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing concluded: "In summary, the conclusion of this meeting was that the time had come for Hepatitis core anti-body testing for plasma. Implementation will probably be achieved during 1984 for the industry."

Published on:

Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing stated: "The approval of our heat-treat submission, in conjunction with core-screened plasma could present us with a potent marketing advantage. We made no mention of our plans to the others."

Published on:

The New England Journal of Medicine published an article by Siegal et al titled "Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions".

Published on:

Inquiry publishes financial report

Published on:

Rhys Brennan

Published on:

At an Association of Haematologists North East Thames Region Working Party in Haemophilia meeting, Dr Lane "projected utilisation of factor VIII concentrate to grow to 60M iu [international units] per annum over a ten-year period" but suggested "100M iu per annum" as a more realistic estimate to achieve self-sufficiency.

Published on:

It was apparent that the fractionation capacity in England would need significant expansion.

Published on: